| Literature DB >> 27634761 |
Sang-Won Um1, Je-Gun Joung2, Hyun Lee3, Hojoong Kim3, Kyu-Tae Kim2, Jinha Park3, D Neil Hayes4, Woong-Yang Park5,6.
Abstract
Tumor heterogeneity influences the clinical outcome of patients with cancer, and the diagnostic method to measure the tumor heterogeneity needs to be developed. We analyzed genomic features on pairs of primary and multiple metastatic lymph nodes from six patients with lung cancer using whole-exome sequencing and RNA sequencing. Although somatic single-nucleotide variants were shared in primary lung cancer and metastases, tumor evolution predicted by the pattern of genomic alterations was matched to anatomic location of the tumors. Four of six cases exhibited a branched clonal evolution pattern. Lymph nodes with acquired somatic variants demonstrated resistance to the cancer treatment. In this study, we demonstrated that multiple biopsies and sequencing strategies for different tumor regions are required for a comprehensive understanding of the landscape of genetic alteration and for guiding targeted therapy in advanced primary lung cancer. Cancer Res; 76(22); 6568-76. ©2016 AACR. ©2016 American Association for Cancer Research.Entities:
Mesh:
Year: 2016 PMID: 27634761 DOI: 10.1158/0008-5472.CAN-16-0873
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701